Paper
10 August 1994 Laser photocoagulation stops diabetic retinopathy by controlling lactic acid formation
Myron Lee Wolbarsht
Author Affiliations +
Proceedings Volume 2097, Laser Applications; (1994) https://doi.org/10.1117/12.183130
Event: Laser Optics, 1993, St. Petersburg, Russian Federation
Abstract
Many different types of proliferative retinopathy induced by various types of initial disorders have a common pathology in their mid and terminal stages. Thus, proper therapy is devoted toward elimination of the initial cause as well as alleviation of the proliferative processes. Vasodilatation, which is an initial symptom of diabetes, is itself destructive to the retinal capillary bed and appears to be a constant feature in all stages of diabetic retinopathy. In the mid and late stages, the vasodilatation seems very dependent upon capillary dropout, whereas the initial vasodilatation may derive from quite different causes. The efficacy of photocoagulation as a therapy for all stages seems to derive from decreasing the metabolism in the photoreceptor layer sufficiently to result in vasoconstriction of the retinal vessels. A model is proposed to show how diabetes, by altering the metabolism in the photoreceptor layer to produce excess lactic acid, causes the initial vasodilatation. The lactic acid also induces free radical (superoxide) formation; both act together to destroy the retinal capillary bed followed by vasoproliferation. Photocoagulation, thus, is even more appropriate for this particular syndrome than previously had been thought, as it not only reduces potentially destructive vasodilatation but also removes the metabolic cause of the free radical induced destruction of the capillary endothelium which is the initial step in capillary drop-out. A review of the present data indicates that the best type of pan- retinal photocoagulation is a very light type affecting the photoreceptors only with a minimal amount of damage to other parts of retina and the vessels in the choroid. The possible use of photochemical types of destruction of the photoreceptor as a therapeutic modality is attractive, but it is certainly too speculative to use until more detailed investigations have been completed. However, the basic therapeutic approach of choice may be to prevent the initial vascular involvement by preventing lactic acid buildup (or keeping the tissue pH normal) or by blocking the generation of superoxide with Allopurinol or similar medication.
© (1994) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Myron Lee Wolbarsht "Laser photocoagulation stops diabetic retinopathy by controlling lactic acid formation", Proc. SPIE 2097, Laser Applications, (10 August 1994); https://doi.org/10.1117/12.183130
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Capillaries

Oxygen

Retina

Laser coagulation

Tissues

Injuries

Mode conditioning cables

Back to Top